Medicus Pharma (MDCX) Debt Ratio (2025)

Medicus Pharma (MDCX) posted Debt Ratio of 0.52 for Q4 2025, down 23.3% quarter-over-quarter from 0.68 in Q3 2025.

Medicus Pharma (MDCX) Debt Ratio (2025) Analysis & Trends

Medicus Pharma (MDCX) has reported Debt Ratio for 1 consecutive years, with 0.52 the latest figure, recorded in Q4 2025.

Debt Ratio for Q4 2025 came in at 0.52, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.52 (changed N/A YoY), and the FY2025 annual result was 0.52, changed N/A from the prior year.
Debt Ratio was 0.52 for Q4 2025 at Medicus Pharma, down from 0.68 in the prior quarter.
Over five years, Debt Ratio peaked at 0.68 in Q3 2025 and troughed at 0.39 in Q2 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	0.37
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	0.27
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	0.47
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	-0.21
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	0.38
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	0.62
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	0.39
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	0.31
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-
10	Medicus Pharma	6.91 Mn	-1.69 Mn	-	0.52

Historic Data

Download Data

Date	Value
Dec 31, 2025	0.52
Sep 30, 2025	0.68
Jun 30, 2025	0.39